As of 2025-07-06, the Fair Value of Cell MedX Corp (CMXC) is -2.46 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.45 USD, the upside of Cell MedX Corp is -650.19%.
With the market price of 0.45 USD and our fair value calculation, Cell MedX Corp (CMXC) is not a good investment. Investing in CMXC stocks now will result in a potential loss of 650.19%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-05-31 | 2021-05-31 | 2022-05-31 | 2023-05-31 | 2024-05-31 | 5Y Avg | |
| Net income | -1.09 | -0.91 | -0.70 | -0.50 | -0.14 | -0.67 |
| YoY growth | -20.61% | 16.64% | 23.44% | 29.01% | 71.22% | 23.94% |
| Market Cap (mil) | 0.62 |
| P/E | |
| Forward P/E |
| EPS | -0.10 |
| Avg earnings growth rate | 23.94% |
| TTM earnings | -0.14 |